掺假尿液样本中的丁丙诺啡、诺丁诺啡和纳洛酮水平:将丁丙诺啡/纳洛酮薄膜浸入尿液或水中能否检测到它们?

Hiroko Furo, M. Whitted, Tony Lin, Yi Y Zhou, Sarah Abdelsayed, Bradley B Brimhall, Peter L Elkin
{"title":"掺假尿液样本中的丁丙诺啡、诺丁诺啡和纳洛酮水平:将丁丙诺啡/纳洛酮薄膜浸入尿液或水中能否检测到它们?","authors":"Hiroko Furo, M. Whitted, Tony Lin, Yi Y Zhou, Sarah Abdelsayed, Bradley B Brimhall, Peter L Elkin","doi":"10.1177/11782218231223673","DOIUrl":null,"url":null,"abstract":"Reportedly, various urine manipulations can be performed by opioid use disorder (OUD) patients who are on buprenorphine/naloxone medications to disguise their non-compliance to the treatment. One type of manipulation is known as “spiking” adulteration, directly dipping a buprenorphine/naloxone film into urine. Identifying this type of urine manipulation has been the aim of many previous studies. These studies have revealed urine adulterations through inappropriately high levels of “buprenorphine” and “naloxone” and a very small amount of “norbuprenorphine.” So, does the small amount of “norbuprenorphine” in the adulterated urine samples result from dipped buprenorphine/naloxone film, or is it a residual metabolite of buprenorphine in the patient’s system? This pilot study utilized 12 urine samples from 12 participants, as well as water samples as a control. The samples were subdivided by the dipping area and time, as well as the temperature and concentration of urine samples, and each sublingual generic buprenorphine/naloxone film was dipped directly into the samples. Then, the levels of “buprenorphine,” “norbuprenorphine,” “naloxone,” “buprenorphine-glucuronide” and “norbuprenorphine-glucuronide” were examined by Liquid Chromatography with tandem mass spectrometry (LC-MS/MS). The results of this study showed that high levels of “buprenorphine” and “naloxone” and a small amount of “norbuprenorphine” were detected in both urine and water samples when the buprenorphine/naloxone film was dipped directly into these samples. However, no “buprenorphine-glucuronide” or “norbuprenorphine-glucuronide” were detected in any of the samples. In addition, the area and timing of dipping altered “buprenorphine” and “naloxone” levels, but concentration and temperature did not. This study’s findings could help providers interpret their patients’ urine drug test results more accurately, which then allows them to monitor patient compliance and help them identify manipulation by examining patient urine test results.","PeriodicalId":516306,"journal":{"name":"Substance Use: Research and Treatment","volume":"16 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Buprenorphine, Norbuprenorphine, and Naloxone Levels in Adulterated Urine Samples: Can They be Detected When Buprenorphine/Naloxone Film is Dipped into Urine or Water?\",\"authors\":\"Hiroko Furo, M. Whitted, Tony Lin, Yi Y Zhou, Sarah Abdelsayed, Bradley B Brimhall, Peter L Elkin\",\"doi\":\"10.1177/11782218231223673\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Reportedly, various urine manipulations can be performed by opioid use disorder (OUD) patients who are on buprenorphine/naloxone medications to disguise their non-compliance to the treatment. One type of manipulation is known as “spiking” adulteration, directly dipping a buprenorphine/naloxone film into urine. Identifying this type of urine manipulation has been the aim of many previous studies. These studies have revealed urine adulterations through inappropriately high levels of “buprenorphine” and “naloxone” and a very small amount of “norbuprenorphine.” So, does the small amount of “norbuprenorphine” in the adulterated urine samples result from dipped buprenorphine/naloxone film, or is it a residual metabolite of buprenorphine in the patient’s system? This pilot study utilized 12 urine samples from 12 participants, as well as water samples as a control. The samples were subdivided by the dipping area and time, as well as the temperature and concentration of urine samples, and each sublingual generic buprenorphine/naloxone film was dipped directly into the samples. Then, the levels of “buprenorphine,” “norbuprenorphine,” “naloxone,” “buprenorphine-glucuronide” and “norbuprenorphine-glucuronide” were examined by Liquid Chromatography with tandem mass spectrometry (LC-MS/MS). The results of this study showed that high levels of “buprenorphine” and “naloxone” and a small amount of “norbuprenorphine” were detected in both urine and water samples when the buprenorphine/naloxone film was dipped directly into these samples. However, no “buprenorphine-glucuronide” or “norbuprenorphine-glucuronide” were detected in any of the samples. In addition, the area and timing of dipping altered “buprenorphine” and “naloxone” levels, but concentration and temperature did not. This study’s findings could help providers interpret their patients’ urine drug test results more accurately, which then allows them to monitor patient compliance and help them identify manipulation by examining patient urine test results.\",\"PeriodicalId\":516306,\"journal\":{\"name\":\"Substance Use: Research and Treatment\",\"volume\":\"16 8\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Substance Use: Research and Treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/11782218231223673\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance Use: Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11782218231223673","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

据报道,正在服用丁丙诺啡/纳洛酮药物的阿片类药物使用障碍(OUD)患者可能会对尿液进行各种处理,以掩盖他们不遵守治疗规定的行为。其中一种操作被称为 "掺假",即直接将丁丙诺啡/纳洛酮薄膜浸入尿液中。以前的许多研究都以识别这种尿液掺假行为为目标。这些研究发现,尿液中掺入的 "丁丙诺啡 "和 "纳洛酮 "含量过高,而 "诺丁诺啡 "含量极少。那么,掺假尿样中的少量 "诺丁诺啡 "是浸泡过丁丙诺啡/纳洛酮胶片的结果,还是患者体内残留的丁丙诺啡代谢物?这项试点研究采用了 12 名参与者的 12 份尿样,以及作为对照的水样。按照浸泡部位、时间以及尿样的温度和浓度对样本进行了细分,并将每片丁丙诺啡/纳洛酮舌下含服普通药膜直接浸泡在样本中。然后,用液相色谱-串联质谱法(LC-MS/MS)检测 "丁丙诺啡"、"诺丁诺啡"、"纳洛酮"、"丁丙诺啡-葡萄糖醛酸苷 "和 "诺丁诺啡-葡萄糖醛酸苷 "的含量。研究结果表明,将丁丙诺啡/纳洛酮薄膜直接浸入尿样和水样中,可检测到高浓度的 "丁丙诺啡 "和 "纳洛酮 "以及少量的 "诺丁诺啡"。不过,在任何样本中都没有检测到 "丁丙诺啡-葡萄糖醛酸 "或 "诺丁诺啡-葡萄糖醛酸"。此外,浸泡的区域和时间会改变 "丁丙诺啡 "和 "纳洛酮 "的含量,但浓度和温度不会。这项研究的发现可以帮助医疗服务提供者更准确地解释患者的尿液药物检测结果,从而使他们能够监控患者的依从性,并通过检查患者的尿液检测结果帮助他们识别操纵行为。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Buprenorphine, Norbuprenorphine, and Naloxone Levels in Adulterated Urine Samples: Can They be Detected When Buprenorphine/Naloxone Film is Dipped into Urine or Water?
Reportedly, various urine manipulations can be performed by opioid use disorder (OUD) patients who are on buprenorphine/naloxone medications to disguise their non-compliance to the treatment. One type of manipulation is known as “spiking” adulteration, directly dipping a buprenorphine/naloxone film into urine. Identifying this type of urine manipulation has been the aim of many previous studies. These studies have revealed urine adulterations through inappropriately high levels of “buprenorphine” and “naloxone” and a very small amount of “norbuprenorphine.” So, does the small amount of “norbuprenorphine” in the adulterated urine samples result from dipped buprenorphine/naloxone film, or is it a residual metabolite of buprenorphine in the patient’s system? This pilot study utilized 12 urine samples from 12 participants, as well as water samples as a control. The samples were subdivided by the dipping area and time, as well as the temperature and concentration of urine samples, and each sublingual generic buprenorphine/naloxone film was dipped directly into the samples. Then, the levels of “buprenorphine,” “norbuprenorphine,” “naloxone,” “buprenorphine-glucuronide” and “norbuprenorphine-glucuronide” were examined by Liquid Chromatography with tandem mass spectrometry (LC-MS/MS). The results of this study showed that high levels of “buprenorphine” and “naloxone” and a small amount of “norbuprenorphine” were detected in both urine and water samples when the buprenorphine/naloxone film was dipped directly into these samples. However, no “buprenorphine-glucuronide” or “norbuprenorphine-glucuronide” were detected in any of the samples. In addition, the area and timing of dipping altered “buprenorphine” and “naloxone” levels, but concentration and temperature did not. This study’s findings could help providers interpret their patients’ urine drug test results more accurately, which then allows them to monitor patient compliance and help them identify manipulation by examining patient urine test results.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信